Top results
1. como utilities e qalys podem fazer parte doscritérios brasileiros de avaliação de tecnologias emsaúdeinstituto nacional de cardiologia ministério da saúde - brasil…
click to add title equity adjusted qalys? qalys and equity adrian towse director of the office of health economics visiting professor london school of economics aes, june…
click to add title equity adjusted qalys? qalys and equity adrian towse director of the office of health economics visiting professor london school of economics aes, june…
* the qalys debate prof. dr. jan j.v. busschbach, ph.d. erasmus mc institute for medical psychology and psychotherapy * health economics comparing different allocations should…
artículos/articles rev med chile 2010; 138 (supl 2): 83-87 los qalys y dalys como indicadores sintéticos de salud nelson alvis1,a, marÍa teresa valenzuela2,b qalys and…
international society for pharmacoeconomics and outcomes research pharmacoeconomics: identifying the issues advisory panel reports (1998 international society for pharmacoeconomics…
jaime calderón centro colaborador: valor conjunto de atributos que le concedemos a un bien o servicio y por los cuales estamos dispuestos a pagar 2 valor meta compartida
prof. karina jahnz-różyk polskie towarzystwo farmakoekonomiczne ispor poland, krakÓw 2012 powierzchnia : 312,000 km2 polska ludność: 38,500,696 rynek farmaceutyczny:…
Профессор Карина Янц-Ружик Польское фармаоэкономическое общество ispor Польша, Краков 2012 Территория:…
hep-14-0498 - revised cost analysis of sofosbuvirribavirin versus sofosbuvirsimeprevir for genotype 1 hcv in interferon ineligibleintolerant individuals liesl m. hagan1,…
qalys or not qalys : that is the question ? qalys or not qalys : that is the question ? j.p. moatti 1 , p. auquier 1-2 , a.-g. le coroller 1 , g. macquart-moulin 1 revue…
powerpoint presentationfifarma symposium managed entry agreements: a health policy mechanism to reconcile access to innovation with healthcare system sustainability ispor
join colleagues to discuss the latest trends in health economics and outcomes research (heor) and help shape the future of heor. ispor is the leading scientific and educational
1 ispor 16th annual international meeting international society for pharmacoeconomics and outcomes research may 21-25, 2011 hilton baltimore • baltimore, md, usa health…
ispor student network newsletter winter 2017/18 - vol. 9, issue 2. dear readers, the ispor student network newsletter committee wishes you all a very happy new year! we hope…
international society for pharmacoeconomics and outcomes research novemberdecember 2012 vol 18 no 6 in this issue letter from the editor president’s message getting connected:…
ispor latin america 2019 ispor américa latina 2019 12-14 september 12-14 septiembre Ágora bogotá international convention centre bogotá colombia data and value in healthcare:…
powerpoint presentation how can policy-makers and clinicians trust the results of a network meta-analysis? a workshop on how to apply the international society for pharmacoeconomics…
perspectives • to review methods of adherence assessment, and barriers to accurately estimating adherence, from the patient-reported outcomes and pharmacoepidemiologic
report ispor brasil 2019marco antonio dos santos elio tanaka director of institutional relations marcelo cunio machado fonseca • jens grueger, stephen stefani (ispor